{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:46:58Z","timestamp":1778626018139,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.mehy.2016.10.025","type":"journal-article","created":{"date-parts":[[2016,10,29]],"date-time":"2016-10-29T04:45:30Z","timestamp":1477716330000},"page":"94-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Conversations between insulin and bone: Potential mechanism of high bone density in patients with Berardinelli-Seip Congenital Lipodystrophy"],"prefix":"10.1016","volume":"97","author":[{"given":"Josivan Gomes","family":"Lima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia Nobrega","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia Helena C.","family":"Nobrega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selma Maria B.","family":"Jeronimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.mehy.2016.10.025_b0005","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrendo.2015.123","article-title":"Congenital generalized lipodystrophies\u2013new insights into metabolic dysfunction","volume":"11","author":"Patni","year":"2015","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.mehy.2016.10.025_b0010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1210\/jcem-14-2-193","article-title":"An undiagnosed endocrinometabolic syndrome: report of 2 cases","volume":"14","author":"Berardinelli","year":"1954","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mehy.2016.10.025_b0015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1651-2227.1959.tb17558.x","article-title":"Lipodystrophy and gigantism with associated endocrine manifestations. A new diencephalic syndrome?","volume":"48","author":"Seip","year":"1959","journal-title":"Acta Paediatr"},{"issue":"9","key":"10.1016\/j.mehy.2016.10.025_b0020","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1210\/jcem.84.9.6103","article-title":"A gene for congenital generalized lipodystrophy maps to human chromosome 9q34","volume":"84","author":"Garg","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.mehy.2016.10.025_b0025","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng585","article-title":"Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13","volume":"28","author":"Magre","year":"2001","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.mehy.2016.10.025_b0030","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jc.2007-1328","article-title":"Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy","volume":"93","author":"Kim","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.mehy.2016.10.025_b0035","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1172\/JCI38660","article-title":"Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy","volume":"119","author":"Hayashi","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2016.10.025_b0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13098-016-0140-x","article-title":"Clinical and laboratory data of a large series of patients with congenital generalized lipodystrophy","volume":"8","author":"Lima","year":"2016","journal-title":"Diabetol Metab Syndr"},{"issue":"7","key":"10.1016\/j.mehy.2016.10.025_b0045","doi-asserted-by":"crossref","first-page":"764","DOI":"10.4158\/EP.13.7.764","article-title":"High bone mass associated with Berardinelli lipodystrophy","volume":"13","author":"Bandeira","year":"2007","journal-title":"Endocr Pract"},{"issue":"8","key":"10.1016\/j.mehy.2016.10.025_b0050","doi-asserted-by":"crossref","first-page":"E1493","DOI":"10.1210\/jc.2014-1353","article-title":"Bone mineral content in patients with congenital generalized lipodystrophy is unaffected by metreleptin replacement therapy","volume":"99","author":"Christensen","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.mehy.2016.10.025_b0055","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1128\/MCB.06465-11","article-title":"Berardinelli-seip congenital lipodystrophy 2\/seipin is a cell-autonomous regulator of lipolysis essential for adipocyte differentiation","volume":"32","author":"Chen","year":"2012","journal-title":"Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.mehy.2016.10.025_b0060","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s00774-014-0569-7","article-title":"Roles of leptin in bone metabolism and bone diseases","volume":"33","author":"Chen","year":"2015","journal-title":"J Bone Miner Metab"},{"issue":"4","key":"10.1016\/j.mehy.2016.10.025_b0065","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3109\/07435800.2013.879168","article-title":"Possible roles of insulin signaling in osteoblasts","volume":"39","author":"Pramojanee","year":"2014","journal-title":"Endocr Res"},{"issue":"2","key":"10.1016\/j.mehy.2016.10.025_b0070","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0092-8674(00)81558-5","article-title":"Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass","volume":"100","author":"Ducy","year":"2000","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.mehy.2016.10.025_b0075","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2337\/db16-0063","article-title":"Skeletal metabolism, fracture risk, and fracture outcomes in type 1 and type 2 diabetes","volume":"65","author":"Sellmeyer","year":"2016","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.mehy.2016.10.025_b0080","first-page":"18","article-title":"Adipogenesis and osteoblastogenesis: trans-differentiation in the pathophysiology of bone disorders","volume":"15","author":"Savopoulos","year":"2011","journal-title":"Hippokratia"},{"issue":"Pt 2","key":"10.1016\/j.mehy.2016.10.025_b0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1242\/jcs.102.2.341","article-title":"Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures","volume":"102","author":"Beresford","year":"1992","journal-title":"J Cell Sci"},{"key":"10.1016\/j.mehy.2016.10.025_b0090","doi-asserted-by":"crossref","first-page":"226","DOI":"10.12659\/MSM.897044","article-title":"Differentiation of bone marrow mesenchymal stem cells in osteoblasts and adipocytes and its role in treatment of osteoporosis","volume":"22","author":"Wang","year":"2016","journal-title":"Med Sci Monit"},{"issue":"3","key":"10.1016\/j.mehy.2016.10.025_b0095","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0092-8674(02)01049-8","article-title":"Leptin regulates bone formation via the sympathetic nervous system","volume":"111","author":"Takeda","year":"2002","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.mehy.2016.10.025_b0100","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1073\/pnas.0308744101","article-title":"Serum leptin level is a regulator of bone mass","volume":"101","author":"Elefteriou","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 1","key":"10.1016\/j.mehy.2016.10.025_b0105","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.33549\/physiolres.931499","article-title":"The effect of leptin on bone: an evolving concept of action","volume":"57","author":"Cirmanova","year":"2008","journal-title":"Physiol Res"},{"issue":"3","key":"10.1016\/j.mehy.2016.10.025_b0110","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.bone.2003.11.020","article-title":"Leptin deficiency produces contrasting phenotypes in bones of the limb and spine","volume":"34","author":"Hamrick","year":"2004","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.mehy.2016.10.025_b0115","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1677\/joe.0.1750405","article-title":"Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo","volume":"175","author":"Cornish","year":"2002","journal-title":"J Endocrinol"},{"issue":"3","key":"10.1016\/j.mehy.2016.10.025_b0120","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bone.2003.11.007","article-title":"Leptin deficiency\u2013lessons in regional differences in the regulation of bone mass","volume":"34","author":"Reid","year":"2004","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.mehy.2016.10.025_b0125","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.metabol.2011.05.016","article-title":"Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women","volume":"60","author":"Sienkiewicz","year":"2011","journal-title":"Metabolism"},{"issue":"11","key":"10.1016\/j.mehy.2016.10.025_b0130","first-page":"3864","article-title":"Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa","volume":"81","author":"Grinspoon","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.mehy.2016.10.025_b0135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrm1837","article-title":"Critical nodes in signalling pathways: insights into insulin action","volume":"7","author":"Taniguchi","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.mehy.2016.10.025_b0140","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1530\/EJE-15-0155","article-title":"Management of endocrine disease: Diabetes and osteoporosis: cause for concern?","volume":"173","author":"Starup-Linde","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.mehy.2016.10.025_b0145","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ajmg.a.20245","article-title":"Congenital generalized lipodystrophy, mental retardation, deafness, short stature, and slender bones: a newly recognized syndrome?","volume":"121A","author":"Rajab","year":"2003","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.mehy.2016.10.025_b0150","doi-asserted-by":"crossref","first-page":"711","DOI":"10.12659\/MSM.890130","article-title":"Differential pattern for regulating insulin secretion, insulin resistance, and lipid metabolism by osteocalcin in male and female T2DM patients","volume":"20","author":"Rui","year":"2014","journal-title":"Med Sci Monit"},{"issue":"3","key":"10.1016\/j.mehy.2016.10.025_b0155","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S8756-3282(98)00095-7","article-title":"Insulin receptor expression in primary and cultured osteoclast-like cells","volume":"23","author":"Thomas","year":"1998","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.mehy.2016.10.025_b0160","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1172\/JCI9017","article-title":"Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover","volume":"105","author":"Ogata","year":"2000","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.mehy.2016.10.025_b0165","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cell.2010.06.003","article-title":"Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism","volume":"142","author":"Ferron","year":"2010","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.mehy.2016.10.025_b0170","doi-asserted-by":"crossref","first-page":"323","DOI":"10.14310\/horm.2002.1552","article-title":"The sclerostin story: from human genetics to the development of novel anabolic treatment for osteoporosis","volume":"13","author":"Yavropoulou","year":"2014","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.mehy.2016.10.025_b0175","article-title":"Increased sclerostin and preadipocyte factor-1 levels in prepubertal rhythmic gymnasts: associations with bone mineral density, body composition, and adipocytokine values","author":"Jurimae","year":"2015","journal-title":"Osteoporos Int"},{"issue":"8","key":"10.1016\/j.mehy.2016.10.025_b0180","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/dc14-2989","article-title":"Sclerostin and insulin resistance in prediabetes: evidence of a cross talk between bone and glucose metabolism","volume":"38","author":"Daniele","year":"2015","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.mehy.2016.10.025_b0185","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/jc.2011-2186","article-title":"Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus","volume":"97","author":"Garcia-Martin","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.mehy.2016.10.025_b0190","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/oby.20077","article-title":"Liver fat and SHBG affect insulin resistance in midlife women: the Study of Women\u2019s Health Across the Nation (SWAN)","volume":"21","author":"Kavanagh","year":"2013","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"10.1016\/j.mehy.2016.10.025_b0195","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/rheumatology\/ket007","article-title":"Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management","volume":"52","author":"Gregson","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.mehy.2016.10.025_b0200","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s11604-007-0166-y","article-title":"Computed tomography findings of congenital generalized lipodystrophy: multiple nodular fatty liver and diffuse sclerosis of bones","volume":"25","author":"Shinya","year":"2007","journal-title":"Radiat Med"},{"issue":"5","key":"10.1016\/j.mehy.2016.10.025_b0205","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2106\/JBJS.N.00648","article-title":"Sarcopenia and fragility fractures: molecular and clinical evidence of the bone-muscle interaction","volume":"97","author":"Tarantino","year":"2015","journal-title":"J Bone Joint Surg Am"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716303656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716303656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T22:29:37Z","timestamp":1749680977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987716303656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":41,"alternative-id":["S0306987716303656"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2016.10.025","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conversations between insulin and bone: Potential mechanism of high bone density in patients with Berardinelli-Seip Congenital Lipodystrophy","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2016.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}